IMB DX

IMB Dx is a precision oncology company that develops minimally-invasive liquid biopsy tests for safe & affordable cancer diagnosis and monitoring. Our liquid biopsy platform AlphaLiquid® is designed for early & advanced cancer patients for the purpose of accurate tumor profiling, therapy selection, recurrence monitoring, and early cancer detection.Our proprietary technology detects and analyzes trace amount of circulating tumor DNA (ctDNA) from a single draw of blood. We are committed to providing useful information for patients and physicians, and to revolutionize the way cancer is diagnosed, monitored, and treated.

#SimilarOrganizations #People #Website #More

IMB DX

Social Links:

Industry:

Biotechnology Health Care

Founded:

2018-07-05

Address:

Seoul, Seoul-t'ukpyolsi, South Korea

Country:

South Korea

Website Url:

http://www.imbdx.com

Total Employee:

11+

Status:

Active

Contact:

+82-2-6951-2906

Email Addresses:

[email protected]

Total Funding:

28 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Google Tag Manager Google Universal Analytics Domain Not Resolving Apache Global Site Tag Mobile Non Scaleable Content